The knowledge we are gaining at n-Lorem has even more value than benefiting nano-rare patients and their families. These insights will enable scientists to discover new therapeutic targets for both common and rare diseases, fundamentally changing the way we approach health and disease.
<a href='https://forms.office.com/r/1ik9WNs7QB'>Survey – Patient Empowerment Program Podcast</a><a href='https://www.nlorem.org/nano-rare-patient-colloquium-2024/'>Register for the 2024 Nano-rare Patient Colloquium</a>On This Episode We Discuss:
<ul><li>Two most common words in medicine: Health and Disease</li>
<li>The Scientific Method</li>
<li>The Importance of Single Variables</li>
<li>Orthogonal Thinking</li>
<li>We Are at a Unique Moment in Medical History</li>
<li>Genomics</li>
<li>Advances in Omics</li>
<li>Biological Networks and AI</li>
<li>Facile Collection, Maintenance, Growth and Differentiation in the Lab</li>
<li>Antisense Technology</li>
</ul>

The knowledge we are gaining at n-Lorem has even more value than benefiting nano-rare patients and their families. These insights will enable scientists to discover new therapeutic targets for both common and rare diseases, fundamentally changing the way we approach health and disease. Survey – Patient Empowerment Program PodcastRegister for the 2024 Nano-rare Patient ColloquiumOn This Episode We Discuss: Two most common words in medicine: Health and Disease The Scientific Method The Importance of Single Variables Orthogonal Thinking We Are at a Unique Moment in Medical History Genomics Advances in Omics Biological Networks and AI Facile Collection, Maintenance, Growth and Differentiation in the Lab Antisense Technology

The knowledge we are gaining at n-Lorem has even more value than benefiting nano-rare patients and their families. These insights will enable scientists to discover new therapeutic targets for both common and rare diseases, fundamentally changing the way we approach health and disease.
<a href="https://forms.office.com/r/1ik9WNs7QB" rel="noopener noreferrer">Survey – Patient Empowerment Program Podcast</a><a href="https://www.nlorem.org/nano-rare-patient-colloquium-2024/" rel="noopener noreferrer">Register for the 2024 Nano-rare Patient Colloquium</a>On This Episode We Discuss:
<ul><li>Two most common words in medicine: Health and Disease</li>
<li>The Scientific Method</li>
<li>The Importance of Single Variables</li>
<li>Orthogonal Thinking</li>
<li>We Are at a Unique Moment in Medical History</li>
<li>Genomics</li>
<li>Advances in Omics</li>
<li>Biological Networks and AI</li>
<li>Facile Collection, Maintenance, Growth and Differentiation in the Lab</li>
<li>Antisense Technology</li>
</ul>

Knowledge is Power: Part 1

Join the nano-rare disease community! Interviews features leading physicians, scientists, biotech experts, and patient advocates. Lessons teach core concepts about drugs. Our host Dr. Crooke has led the creation of antisense technology and his foundation, n-Lorem, is using this powerful technology to discover, develop, and provide personalized experimental antisense oligonucleotide medicines to nano-rare patients for free, for life. 

n-Lorem is a non-profit organization established to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide (ASO) medicines to treat patients (less than 30 patients) that are the result of a single genetic defect unique to only one or very few individuals. The advantage of experimental ASO medicines is that they can be developed rapidly, inexpensively and are highly specific. n-Lorem was founded by Dr. Stan Crooke, who founded IONIS Pharmaceuticals in 1989 and, through his vision and leadership, established the company as the leader in RNA-targeted therapeutics. 

The podcast is produced by n-Lorem Foundation and hosted by Dr. Stanley T. Crroke, who is the Founder, CEO and Chairman. Our videographer is Jon Magnuson. Our producers are Kira Dineen, Jon Magnuson, Kim Butler, and Amy Williford. To learn more about n-Lorem, visit nlorem.org. Contact us at podcast@nlorem.org.

Science

Medicine

Health & Fitness

Education

Life Sciences

Join the nano-rare disease community! Interviews features leading physicians, scientists, biotech experts, and patient advocates. Lessons teach core concepts about drugs. Our host Dr. Crooke has led the creation of antisense technology and his foundation, n-Lorem, is using this powerful technology to discover, develop, and provide personalized experimental antisense oligonucleotide medicines to nano-rare patients for free, for life. n-Lorem is a non-profit organization established to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide (ASO) medicines to treat patients (less than 30 patients) that are the result of a single genetic defect unique to only one or very few individuals. The advantage of experimental ASO medicines is that they can be developed rapidly, inexpensively and are highly specific. n-Lorem was founded by Dr. Stan Crooke, who founded IONIS Pharmaceuticals in 1989 and, through his vision and leadership, established the company as the leader in RNA-targeted therapeutics. The podcast is produced by n-Lorem Foundation and hosted by Dr. Stanley T. Crroke, who is the Founder, CEO and Chairman. Our videographer is Jon Magnuson. Our producers are Kira Dineen, Jon Magnuson, Kim Butler, and Amy Williford. To learn more about n-Lorem, visit nlorem.org. Contact us at podcast@nlorem.org.

Share Knowledge is Power: Part 1

Sign up to save your podcasts

Knowledge is Power: Part 1

Knowledge is Power: Part 1

More shows like Patient Empowerment Program: A Rare Disease Podcast

This American Life

Embedded

The Daily

Crime Junkie

The Readout Loud

The Weekly Show with Jon Stewart

BioSpace